| Report Title | Price | Action |
|---|---|---|
| Postherpetic Neuralgia (Central Nervous System) - Drugs in Development, 2021
Postherpetic Neuralgia (Central Nervous System) - Drugs in Development, 2021 Summary Postherpetic Neuralgia (Central Nervous System) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Back Pain (Central Nervous System) - Drugs in Development, 2021
Back Pain (Central Nervous System) - Drugs in Development, 2021 Summary Back Pain (Central Nervous System) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Drugs in Development, 2021
Cells Expressing Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Drugs in Development, ...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cysteine S Nitrosylase GAPDH or GAPDH or EC 1.2.1.12) - Drugs in Development, 2021
Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cysteine S Nitrosylase GAPDH or GAPDH or EC 1.2.1.12) - Drugs in Development, 2021 Summary Glycer...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Sezary Syndrome (Oncology) - Drugs in Development, 2021
Sezary Syndrome (Oncology) - Drugs in Development, 2021 Summary Sezary Syndrome (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Premature Ovarian Failure (Women's Health) - Drugs in Development, 2021
Premature Ovarian Failure (Women's Health) - Drugs in Development, 2021 Summary Premature Ovarian Failure (Women's Health) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Carotid Artery Stenosis (Cardiovascular) - Drugs in Development, 2021
Carotid Artery Stenosis (Cardiovascular) - Drugs in Development, 2021 Summary Carotid Artery Stenosis (Cardiovascular) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021
Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 Summary Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Chronic Bronchitis (Respiratory) - Drugs in Development, 2021
Chronic Bronchitis (Respiratory) - Drugs in Development, 2021 Summary Chronic Bronchitis (Respiratory) - Drugs in Development, 2021 provides an over...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Trophoblast Glycoprotein (M6P1 or 5T4 Oncofetal Antigen or 5T4 Oncofetal Trophoblast Glycoprotein or Wnt Activated Inhibitory Factor 1 or TPBG) - Drugs in Development, 2021
Cells Expressing Trophoblast Glycoprotein (M6P1 or 5T4 Oncofetal Antigen or 5T4 Oncofetal Trophoblast Glycoprotein or Wnt Activated Inhibitory Factor ...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Hepatitis B Virus DNA Polymerase (Hepatitis B Virus Reverse Transcriptase or Hepatitis B Virus Ribonuclease H or EC 2.7.7.7 or EC 2.7.7.49 or EC 3.1.26.4) - Drugs in Development, 2021
Hepatitis B Virus DNA Polymerase (Hepatitis B Virus Reverse Transcriptase or Hepatitis B Virus Ribonuclease H or EC 2.7.7.7 or EC 2.7.7.49 or EC 3.1.2...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) (Oncology) - Drugs in Development, 2021
Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) (Oncology) - Drugs in Development, 2021 Summary Leptomeningeal Disease...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021
Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021 Summary Cerebrovascular Disease (Cardiovascular) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Endocarditis (Cardiovascular) - Drugs in Development, 2021
Endocarditis (Cardiovascular) - Drugs in Development, 2021 Summary Endocarditis (Cardiovascular) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021
Primary Progressive Multiple Sclerosis (PPMS) (Central Nervous System) - Drugs in Development, 2021 Summary Primary Progressive Multiple Sclerosis (...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Chronic Cough (Respiratory) - Drugs in Development, 2021
Chronic Cough (Respiratory) - Drugs in Development, 2021 Summary Chronic Cough (Respiratory) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Fibrinogen (Coagulation Factor I or FG) - Drugs in Development, 2021
Fibrinogen (Coagulation Factor I or FG) - Drugs in Development, 2021 Summary Fibrinogen (Coagulation Factor I or FG) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Hepatitis C Virus Envelope Protein E1 - Drugs in Development, 2021
Hepatitis C Virus Envelope Protein E1 - Drugs in Development, 2021 Summary Hepatitis C Virus Envelope Protein E1 - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Drugs in Development, 2021
Dual Specificity Mitogen Activated Protein Kinase Kinase 2 (ERK Activator Kinase 2 or MAPK/ERK Kinase 2 or MAP2K2 or EC 2.7.12.2) - Drugs in Developme...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021 Summary Neuroendocrine Gastroenteropancreatic Tumors ...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 |